- This blog is a discussion about our system of public and private health care.
-

Blogroll
About Me
Alison Bass is a Pulitzer Prize nominee and author of Side Effects: A Prosecutor, a Whistleblower and a Bestselling Antidepressant on Trial, which won the NASW Science in Society Award. She was a longtime medical and science writer for The Boston Globe and has also written for The Miami Herald, Psychology Today and MIT's Technology Review, among other publications. A series she wrote for The Boston Globe on psychiatry was nominated for a Pulitzer Prize and she has received many other journalism awards. In 2007, she won a prestigious Alicia Patterson Fellowship to write Side Effects. Bass teaches journalism at Mount Holyoke College and Brandeis University.Blog Archive
- February 2013 (1)
- November 2012 (1)
- October 2012 (1)
- September 2012 (4)
- August 2012 (1)
- July 2012 (2)
- June 2012 (3)
- May 2012 (3)
- April 2012 (2)
- February 2012 (2)
- January 2012 (3)
- December 2011 (3)
- November 2011 (3)
- October 2011 (2)
- September 2011 (4)
- August 2011 (3)
- July 2011 (3)
- June 2011 (4)
- May 2011 (4)
- April 2011 (3)
- March 2011 (3)
- February 2011 (3)
- January 2011 (4)
- December 2010 (3)
- November 2010 (2)
- September 2010 (2)
- July 2010 (1)
- May 2010 (1)
- April 2010 (1)
- March 2010 (3)
- February 2010 (3)
- January 2010 (4)
- December 2009 (4)
- November 2009 (5)
- October 2009 (4)
- September 2009 (6)
- August 2009 (7)
- July 2009 (4)
- June 2009 (5)
- May 2009 (4)
- April 2009 (7)
- March 2009 (4)
- February 2009 (3)
- January 2009 (4)
- December 2008 (4)
- November 2008 (3)
- October 2008 (4)
- September 2008 (5)
- August 2008 (2)
- July 2008 (6)
- June 2008 (5)
- May 2008 (1)
- April 2008 (1)
Monthly Archives: September 2008
Internal documents reveal extent of Paxil drug study chicanery
Share When I was a reporter for The Boston Globe in the 90s, an employee of Brown University’s department of psychiatry handed me a raft of internal university documents. A number of these documents pertained to an ongoing clinical trial … Continue reading
Posted in Uncategorized
Leave a comment
Student newspaper gives Brown a black eye
Share In June when the news broke that U.S. Senator Charles Grassley was probing the financial ties between Martin Keller, the chief of psychiatry at Brown University, and the drug industry, Brown officials tried to stonewall the entire issue. They … Continue reading
Posted in Uncategorized
1 Comment
What the New York Times article on bipolar children didn’t say…
Share I have to say I’m disappointed with the cover story on bipolar children in Sunday’s New York Times magazine. The author, Jennifer Egan, raises the interesting question about why there has been such a sharp increase in the diagnosis … Continue reading
Posted in Uncategorized
Leave a comment
Can America’s premier psychiatric assocation heal itself?
Share Judging by its response to the Senate Finance Committee, the leadership of the American Psychiatric Association (APA) still doesn’t seem to get it. For the past several months, the Finance Committee has been investigating conflicts of interest between academic … Continue reading
Posted in Uncategorized
Leave a comment
Antidepressants and Suicide Rates: Another Salvo in the Debate
Share Remember all those dire warnings from the psychiatric community that youth suicides would rise after the FDA put black box warnings on antidepressants in late 2004? The argument was that physicians would be scared away from prescribing these drugs … Continue reading
Posted in Uncategorized
2 Comments